CONMED’s shares receive ‘hold’ rating — 5 points

Zacks upgraded CONMED’s shares to a ‘hold’ rating on Nov. 19, according to Dakota Financial News.

Advertisement

Here are five points:

 

1. Zacks stated CONMED’s sales were negatively impacted by foreign exchange.

 

2. CONMED’s shares traded up 0.84 percent to $42.17 on Nov. 19.

 

3. On Nov. 19, 15,771 shares were exchanged.

 

4. The company has a 12-month-low of $37.94 and a 12-month-high of $60.66.

 

5. Its 50-day moving average is $44.04 and its 200-day moving average is $52.43.

 

More articles on devices:
Memorial Medical Center gets new surgical system — 5 key points
New Bay Area device uses a precise knee replacement for surfer — 4 things to know
Dr. Richard Buch performs surgery using rare Implantcast — 7 key facts

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.